Get started
Author

Kamal A. Albarazanji

Observed names: K A Al‐Barazanji, K al‐Barazanji, K. A. Al-Barazanji, K. A. Al‐Barazanji, K. Al-Barazanji, K.A. Al-Barazanji, KAMAL A AL-BARAZANJI, KAMAL A. ALBARAZANJI, Kamal A Al-Barazanji, Kamal A. Al-Barazanji, Kamal A. Al‐Barazanji, Kamal Al-Barazanji, Kamal Albarazanji
Observed institutions: Johnson & Johnson (United States), Janssen (Belgium), GlaxoSmithKline (United Kingdom), University of Manchester, GlaxoSmithKline (United States), Janssen (United States), Janssen Research & Development (United States)
OpenAlex ID: A5111810290
Interactions Between Leptin and Hypothalamic Neuropeptide Y Neurons in the Control of Food Intake and Energy Homeostasis in the Rat
1997 · Qiong Wang, Chen Bing, et al. · Diabetes · 293
Central Exendin‐4 Infusion Reduces Body Weight without Altering Plasma Leptin in (fa/fa) Zucker Rats
2000 · Kamal A. Al‐Barazanji, Jonathan R. S. Arch, et al. · Obesity Research · 209
Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats
1998 · Robin E Buckingham, Kamal A Al-Barazanji, et al. · Diabetes · 209
Central Orexin‐A Activates Hypothalamic‐Pituitary‐Adrenal Axis and Stimulates Hypothalamic Corticotropin Releasing Factor and Arginine Vasopressin Neurones in Conscious Rats
2001 · K. A. Al‐Barazanji, S. Wilson, et al. · Journal of Neuroendocrinology · 146
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
2006 · Donald L. Hertzog, Kamal A. Al-Barazanji, et al. · Bioorganic & Medicinal Chemistry Letters · 49
Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1
2006 · Francis X. Tavares, Kamal A. Al-Barazanji, et al. · Journal of Medicinal Chemistry · 35
Orexin Expression and Function: Glucocorticoid Manipulation, Stress, and Feeding Studies
2005 · Gemma K. Ford, Kamal A. Al-Barazanji, et al. · Endocrinology · 35
Novel benzimidazole-based MCH R1 antagonists
2006 · Andrew J. Carpenter, Kamal A. Al-Barazanji, et al. · Bioorganic & Medicinal Chemistry Letters · 28
Effects of Intracerebroventricular Infusion of Leptin in Obese Zucker Rats
1997 · Kamal A. Al‐Barazanji, Robin E. Buckingham, et al. · Obesity Research · 27
PDF
Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits
2020 · Weimei Sun, Xuqing Zhang, et al. · Journal of Pharmacology and Experimental Therapeutics · 24
PDF
C-Terminal Fragments of ACTH Stimulate Feeding in Fasted Rats
2001 · K. A. Al-Barazanji, J. E. Miller, et al. · Hormone and Metabolic Research · 23
Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
2006 · David R. Witty, John Bateson, et al. · Bioorganic & Medicinal Chemistry Letters · 22
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist
2006 · Francis X. Tavares, Kamal A. Al-Barazanji, et al. · Journal of Medicinal Chemistry · 20
Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice
2015 · Kamal Al-Barazanji, Judi McNulty, et al. · Journal of Pharmacology and Experimental Therapeutics · 19
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice
2019 · Kamal Albarazanji, Matthew Jennis, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 13
PDF
The renal and vascular effects of central angiotensin II and atrial natriuretic factor in the anaesthetized rat.
1990 · K A Al‐Barazanji, R J Balment · The Journal of Physiology · 13
Central and peripheral effects of the peptide ANF on renal function and blood pressure in hypertensive rats.
1989 · K al‐Barazanji, R J Balment · The Journal of Physiology · 8
Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome
2021 · Xuqing Zhang, Bin Zhu, et al. · Bioorganic & Medicinal Chemistry Letters · 6
Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker rats
2001 · K. A. Al‐Barazanji, R. E. Buckingham, et al. · Diabetes Obesity and Metabolism · 5
Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates
2021 · Kamal Albarazanji, Andrea R. Nawrocki, et al. · Scientific Reports · 4
PDF
The identification of a novel renin inhibitor of equivalent efficacy following oral or intravenous administration.
1994 · S.A. Smith, K.A. Al-Barazanji, et al. · Bioorganic & Medicinal Chemistry Letters · 3
Pan AMPK activation protects tubules in rat ischemic acute kidney injury
2024 · Henriette Frikke-Schmidt, Kamal Albarazanji, et al. · Journal of Pharmacology and Experimental Therapeutics · 2
Indices of Carbohydrate and Lipid Metabolism in Vasopressin-Replete and -Deficient New Zealand Genetically Hypertensive Rats
1998 · K. Al-Barazanji, R. Buckingham, et al. · Hormone and Metabolic Research · 2
Role of CCK1 receptor in metabolic benefits of intestinal enteropeptidase inhibition in mice
2025 · Kamal Albarazanji, Simon A. Hinke, et al. · PLoS ONE · 1
PDF
1104 - Intestinal Serine Protease Inhibition Increases Liver FGF21 Secretion in Diabetic Obese Mice
2018 · Matthew Jennis, Kamal Albarazanji, et al. · Gastroenterology · 1
Works count: 33
Citation count: 1,197
H-index: 14
I10-index: 16
Year
Topic
Type